Exploring the Future of Diagnostic Industry
Emerging Breakthroughs in Diagnosis and their Impact on Patient Management
DOI:
https://doi.org/10.32553/ijmsdr.v8i3.1036Abstract
IVDs constitute one of the major mainstays in today’s healthcare system. The utilization of advanced technologies for disease diagnosis can improve patient outcomes and aid in monitoring and treatment of the disease. The developments of AI tools can aid in maximizing patient care with multiple chronic conditions (MCC) by envisaging drug receptivity, adherence and interactions, while using data repositories to provide personalized medicine and care. The POCT can aid in rapid diagnosis which can be helpful for timely management of the disease. The use of non-invasive liquid biopsy helps in the detection of a broader range of cancers and other diseases at earlier stages. Moreover, it can support in detection of tumor recurrence and real-time monitoring of tumor dynamics and treatment response by recognizing specific markers in body fluids. Integration of digital technologies into healthcare platforms has several advantages. Electronic Health Records (EHRs), telemedicine, mobile health apps (mHealth), wearable devices, Laboratory Information Management System (LIMS) are some of the examples of cutting-edge digital technologies. Block chain technology can help in clinical trial management. Genomic medicine can be potentially useful in diagnosing rare disease genetic conditions, and many types of cancer. These futuristic prospects seem to have huge scope of technology based diagnosis thereby providing accurate results with small TATs aiding in timely and correct clinical decisions by HCPs for the patients.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 International Journal of Medical Science And Diagnosis Research
This work is licensed under a Creative Commons Attribution 4.0 International License.